Search

everythinglearnresearchcommunity

for

Search:↓

Carcinosin, a homeopathic remedy, helped a young girl with alopecia areata regrow hair and reduce psychological symptoms.

The SBN system effectively assesses alopecia areata severity and predicts its course.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Wigs significantly improve the well-being of people with severe hair loss.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Human placental extract effectively and safely improves melasma, ulcers, and alopecia areata.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Changes in skin bacteria may relate to alopecia areata severity.

Baricitinib significantly regrows hair in severe alopecia areata patients.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.